MITOGEN is commercializing a medical device implant that induces the body to regenerate the cartilage tissue, or meniscus, of the knee. The technology has additional applications including spinal disc replacement, rotator cuff, ACL and TMJ repair. Mitogen recenly spun out of Columbia University and will begin human clinical trials. Successful trials in sheep, a large animal model recognized by the FDA as similar to the human knee, concluded that the regenerated meniscus had mechanical properties similar to the natural meniscus. 700,000 patients a year have knee replacement surgery due to Osteoarthritis (OA), a number that is expected to grow to 3.5M over the next 15 years.
| Website | http://www.mitogeninc.com |
| Revenue | $2.8 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2015 |
| Address | 1950 E. Greyhound Pass Ste. 18-232, Carmel, Indiana 46033, US |
| Phone | +1 317-793-8222 |
| Keywords | Cartilage Regeneration, Orthopedic Implants, Meniscus Repair, Knee Surgery, Orthopedic Surgery, Medical Implants, Joint Repair, Regenerative Medicine, Biological Implants, Tissue Regeneration, Tissue Engineering, Cartilage Repair, Rotator Cuff Repair, Medical Devices, Orthopedics, Regenerative Technology |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Eppendorf Group, Fisher Scientific, Takara Bio USA, Inc. +45 more (view full list) |
Looking for a particular Mitogen employee's phone or email?
Mitogen Questions
The Mitogen annual revenue was $2.8 million in 2026.
Mitogen is based in Carmel, Indiana.
Related Companies
